Julia Etchin

2.4k citations

18 papers · 1.4k indexed · 1 hit paper · h-index 11

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Molecular Biology top 10%
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- DNA Repair Mechanisms
- Nuclear Structure and Function
- Protein Degradation and Inhibitors
- CRISPR and Genetic Engineering
- RNA modifications and cancer

Papers in ⓘ

Hematology 8
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 2
Molecular Biology 14
- Nuclear Structure and Function 5
- Genomics and Chromatin Dynamics 3
- RNA Research and Splicing 2
- CRISPR and Genetic Engineering 2
- DNA Repair Mechanisms 2

Co-authors: A. Thomas Look (12 shared papers)Marc R. Mansour (6 shared papers)Takaomi Sanda (7 shared papers)Alla Berezovskaya (6 shared papers)Richard A. Young (2 shared papers)Brian J. Abraham (2 shared papers)Adam D. Durbin (1 shared paper)Lars Anders (1 shared paper)
Journals: Blood (4 papers)British Journal of Haematology (2 papers)Leukemia (2 papers)Cancer Research (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States Singapore United Kingdom

In The Last Decade

Julia Etchin

17 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element 2014 · 538 citations

Peers

Countries citing papers authored by Julia Etchin

Since Specialization

Citations

This map shows the geographic impact of Julia Etchin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Etchin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Etchin more than expected).

Fields of papers citing papers by Julia Etchin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Etchin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Etchin. The network helps show where Julia Etchin may publish in the future.

Co-authors

The 25 scholars most cited alongside Julia Etchin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julia Etchin Line = papers co-authored together Julia Etchin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element Science ·Marc R. Mansour, Brian J. Abraham, Lars Anders, Alla Berezovskaya, Alejandro Gutiérrez, Adam D. Durbin, Julia Etchin, Lee N. Lawton, Stephen E. Sallan, Lewis B. Silverman, Mignon L. Loh, Stephen P. Hunger, Takaomi Sanda, Richard A. Young, A. Thomas Look Hit paper breakdown →	2014	538
2	Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells Leukemia ·Julia Etchin, Qingxiang Sun, Alex Kentsis, Alicia Farmer, Zhong-Zhe Zhang, Takaomi Sanda, Marc R. Mansour, Carles Barceló, Dilara McCauley, Michael Kauffman, Sharon Shacham, Amanda L. Christie, Andrew L. Kung, Scott J. Rodig, Yuh Min Chook, A. Thomas Look	2012	145
3	KPT‐330 inhibitor of CRM1 (XPO1)‐mediated nuclear export has selective anti‐leukaemic activity in preclinical models of T‐cell acute lymphoblastic leukaemia and acute myeloid leukaemia British Journal of Haematology ·Julia Etchin, Takaomi Sanda, Marc R. Mansour, Alex Kentsis, Joan Montero, Bonnie Le, Amanda L. Christie, Dilara McCauley, Scott J. Rodig, Michael Kauffman, Sharon Shacham, Richard M. Stone, Anthony Letai, Andrew L. Kung, A. Thomas Look	2013	141
4	Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2 Nature Structural & Molecular Biology ·Eloïse Dray, Julia Etchin, Claudia Wiese, Dorina Saro, Gareth J. Williams, Michal Hammel, Xiong Yu, Vitold E. Galkin, Dongqing Liu, Miaw-Sheue Tsai, Shirley M.-H. Sy, David Schild, Edward H. Egelman, Junjie Chen, Patrick Sung	2010	128
5	Recombination Mediator and Rad51 Targeting Activities of a Human BRCA2 Polypeptide Journal of Biological Chemistry ·Joseph San Filippo, Peter Chi, Michael G. Sehorn, Julia Etchin, Lumír Krejčí, Patrick Sung	2006	105
6	KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells Leukemia ·Julia Etchin, Alla Berezovskaya, Amy Saur Conway, Ilene Galinsky, Richard M. Stone, Erkan Baloglu, William Senapedis, Yosef Landesman, Michael Kauffman, Sharon Shacham, Jean Wang, A. Thomas Look	2016	89
7	Small genomic insertions form enhancers that misregulate oncogenes Nature Communications ·Brian J. Abraham, Denes Hnisz, Abraham S. Weintraub, Nicholas Kwiatkowski, Charles H. Li, Zhaodong Li, Nina Weichert‐Leahey, Sunniyat Rahman, Yu Liu, Julia Etchin, Benshang Li, Shuhong Shen, Tong Ihn Lee, Jinghui Zhang, A. Thomas Look, Marc R. Mansour, Richard A. Young	2017	62
8	Ribonucleoprotein HNRNPA2B1 Interacts With and Regulates Oncogenic KRAS in Pancreatic Ductal Adenocarcinoma Cells Gastroenterology ·Carles Barceló, Julia Etchin, Marc R. Mansour, Takaomi Sanda, M. Morell, Víctor J. Sánchez‐Arévalo Lobo, Francisco X. Real, Gabriel Capellá, Josep Marı́a Estanyol, Montserrat Jaumot, A. Thomas Look, Neus Agell	2014	51
9	Zebrafish as a Model for the Study of Human Cancer Methods in cell biology ·Julia Etchin, John P. Kanki, A. Thomas Look	2011	43
10	A Small-Molecule Enhancer of Signal Transducer and Activator of Transcription 1 Transcriptional Activity Accentuates the Antiproliferative Effects of IFN-γ in Human Cancer Cells Cancer Research ·Rebecca A. Lynch, Julia Etchin, Traci E. Battle, David A. Frank	2007	41
11	Anti‐leukaemic activity of the TYK2 selective inhibitor NDI‐031301 in T‐cell acute lymphoblastic leukaemia British Journal of Haematology ·Koshi Akahane, Zhaodong Li, Julia Etchin, Alla Berezovskaya, Evisa Gjini, C. E. Masse, Wenyan Miao, Jennifer L. Rocnik, Rosana Kapeller, Jeremy R. Greenwood, Hong L. Tiv, Takaomi Sanda, David M. Weinstock, A. Thomas Look	2017	28
12	Anti-Leukemic Activity of the TYK2 Selective Inhibitor Ndi-031301 in T-Cell Acute Lymphoblastic Leukemia Blood ·Koshi Akahane, Zhaodong Li, Julia Etchin, Alla Berezovskaya, Evisa Gjini, C. E. Masse, Wenyan Miao, Jennifer L. Rocnik, Rosana Kapeller, Jeremy R. Greenwood, Hong L. Tiv, Takaomi Sanda, David M. Weinstock, A. Thomas Look	2016	8
13	Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity Molecular Therapy — Methods & Clinical Development ·John R. Lydeard, Michelle I. Lin, Huanying Gary Ge, Amanda L. Halfond, Shu Wang, Mark B. Jones, Julia Etchin, Gabriella Angelini, Juliana Xavier-Ferrucio, Jessica Lisle, Kienan Salvadore, Yonina Keschner, Hannah Mager, Julian Scherer, Jianxin Hu, Siddhartha Mukherjee, Tirtha Chakraborty	2023	7
14	Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss Oncogene ·Shuning He, Mark W. Zimmerman, Hillary M. Layden, Alla Berezovskaya, Julia Etchin, Megan W. Martel, Grace Thurston, Changbin Jing, Ellen van Rooijen, Charles K. Kaufman, Scott J. Rodig, Leonard I. Zon, E. Elizabeth Patton, Marc R. Mansour, A. Thomas Look	2021	4
15	Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia Blood ·Andrew E. Place, Traci M. Blonquist, Elliot Stieglitz, Todd M. Cooper, Lia Gore, Richard Aplenc, Mignon L. Loh, Melinda Pauly, Rachel E. Rau, Michael J. Burke, Julia Etchin, A. Thomas Look, Maria Luisa Sulis, Lewis B. Silverman	2018	4
16	Multimodal Atlas of Paired Diagnosis and Relapse AML Samples Enables Novel Therapeutic Targeting of Surface Antigens Blood ·Amanda L. Halfond, Matthew Ung, Julia Etchin, Yonina Keschner, Julia DiFazio, Alyssa Pyclik, Guy Mundelboim, Gary Ge, John R. Lydeard, Tirtha Chakraborty	2023	1
17	KPT-SINE, a Potent, Small Molecule Inhibitor of CRM1-Dependent Nuclear-Cytoplasmic Shuttling, with Potent Activity Against T-ALL and AML Blood ·Julia Etchin, Alex Kentsis, Takaomi Sanda, Andrew L. Kung, Richard M. Stone, Dilara McCauley, Michael Kauffman, Sharon Shacham, Thomas Look	2011	1
18	Abstract 39: XPO1 inhibitor, KPT-8602, is well tolerated and highly active against AML blasts and LICs Clinical Cancer Research ·Julia Etchin, Alla Berezovskaya, Amy Saur Conway, Ilene Galinsky, Richard M. Stone, Erkan Baloglu, William Senapedis, Yosef Landesman, Michael Kauffman, Sharon Shacham, Jean Wang, A. Thomas Look	2017	0

About Julia Etchin

Julia Etchin is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Allergy and Cancer Research, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Nuclear Structure and Function (5 papers), Cytokine Signaling Pathways and Interactions (3 papers), Genomics and Chromatin Dynamics (3 papers), RNA Research and Splicing (2 papers), CRISPR and Genetic Engineering (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Hematology (232 citations), Molecular Biology (1.2k citations), Cancer Research (184 citations), Oncology (297 citations) and Genetics (74 citations). Julia Etchin has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include A. Thomas Look, Marc R. Mansour, Takaomi Sanda, Alla Berezovskaya, Richard A. Young, Brian J. Abraham, Adam D. Durbin, Lars Anders, Stephen E. Sallan and Mignon L. Loh. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact